Biotechnology company 10x Genomics and Harvard University reached a Feb. 6 settlement in a patent lawsuit that they jointly ...

A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

/PlutoChain/ – XRP is trading in the green once again, with some analysts predicting it could face a 10X surge soon. Donald ...

Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received a consensus recommendation of “Hold” from the seventeen analysts ...

XRP’s path to a 10x surge depends on Japan’s adoption, with 80% of its banks expected to integrate Ripple’s technology by the ...

TD Cowen analyst Dan Brennan lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps a Hold rating on the shares. The ...